These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 9488389)

  • 1. Transposon-derived Brucella abortus rough mutants are attenuated and exhibit reduced intracellular survival.
    Allen CA; Adams LG; Ficht TA
    Infect Immun; 1998 Mar; 66(3):1008-16. PubMed ID: 9488389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Brucella abortus O-polysaccharide and core lipopolysaccharide mutants and demonstration that a complete core is required for rough vaccines to be efficient against Brucella abortus and Brucella ovis in the mouse model.
    Monreal D; Grilló MJ; González D; Marín CM; De Miguel MJ; López-Goñi I; Blasco JM; Cloeckaert A; Moriyón I
    Infect Immun; 2003 Jun; 71(6):3261-71. PubMed ID: 12761107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementation of Brucella abortus RB51 with a functional wboA gene results in O-antigen synthesis and enhanced vaccine efficacy but no change in rough phenotype and attenuation.
    Vemulapalli R; He Y; Buccolo LS; Boyle SM; Sriranganathan N; Schurig GG
    Infect Immun; 2000 Jul; 68(7):3927-32. PubMed ID: 10858205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of a Tn5-disrupted glycosyltransferase gene homolog in Brucella abortus and its effect on lipopolysaccharide composition and virulence.
    McQuiston JR; Vemulapalli R; Inzana TJ; Schurig GG; Sriranganathan N; Fritzinger D; Hadfield TL; Warren RA; Lindler LE; Snellings N; Hoover D; Halling SM; Boyle SM
    Infect Immun; 1999 Aug; 67(8):3830-5. PubMed ID: 10417145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival of smooth, rough and transposon mutant strains of Brucella abortus in bovine mammary macrophages.
    Price RE; Templeton JW; Adams LG
    Vet Immunol Immunopathol; 1990 Dec; 26(4):353-65. PubMed ID: 1963714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
    Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P
    Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brucella abortus rough mutants are cytopathic for macrophages in culture.
    Pei J; Ficht TA
    Infect Immun; 2004 Jan; 72(1):440-50. PubMed ID: 14688125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of the Brucella abortus phosphoglucomutase gene: role of lipopolysaccharide in virulence and intracellular multiplication.
    Ugalde JE; Czibener C; Feldman MF; Ugalde RA
    Infect Immun; 2000 Oct; 68(10):5716-23. PubMed ID: 10992476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interruption of the cydB locus in Brucella abortus attenuates intracellular survival and virulence in the mouse model of infection.
    Endley S; McMurray D; Ficht TA
    J Bacteriol; 2001 Apr; 183(8):2454-62. PubMed ID: 11274104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increases of efficacy as vaccine against Brucella abortus infection in mice by simultaneous inoculation with avirulent smooth bvrS/bvrR and rough wbkA mutants.
    Grilló MJ; Manterola L; de Miguel MJ; Muñoz PM; Blasco JM; Moriyón I; López-Goñi I
    Vaccine; 2006 Apr; 24(15):2910-6. PubMed ID: 16439039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brucella abortus cyclic beta-1,2-glucan mutants have reduced virulence in mice and are defective in intracellular replication in HeLa cells.
    Briones G; Iñón de Iannino N; Roset M; Vigliocco A; Paulo PS; Ugalde RA
    Infect Immun; 2001 Jul; 69(7):4528-35. PubMed ID: 11401996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic, immunologic and genetic characterization of rough strains B. abortus RB51, B. melitensis B115 and B. melitensis B18.
    Adone R; Muscillo M; La Rosa G; Francia M; Tarantino M
    PLoS One; 2011; 6(10):e24073. PubMed ID: 22065984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and protective property of Brucella abortus cydC and looP mutants.
    Truong QL; Cho Y; Barate AK; Kim S; Hahn TW
    Clin Vaccine Immunol; 2014 Nov; 21(11):1573-80. PubMed ID: 25253663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lipopolysaccharide of Brucella abortus BvrS/BvrR mutants contains lipid A modifications and has higher affinity for bactericidal cationic peptides.
    Manterola L; Moriyón I; Moreno E; Sola-Landa A; Weiss DS; Koch MH; Howe J; Brandenburg K; López-Goñi I
    J Bacteriol; 2005 Aug; 187(16):5631-9. PubMed ID: 16077108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role in virulence of a Brucella abortus protein exhibiting lectin-like activity.
    Vemulapalli TH; Vemulapalli R; Schurig GG; Boyle SM; Sriranganathan N
    Infect Immun; 2006 Jan; 74(1):183-91. PubMed ID: 16368972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periplasmic protein EipA determines envelope stress resistance and virulence in Brucella abortus.
    Herrou J; Willett JW; Fiebig A; Varesio LM; Czyż DM; Cheng JX; Ultee E; Briegel A; Bigelow L; Babnigg G; Kim Y; Crosson S
    Mol Microbiol; 2019 Mar; 111(3):637-661. PubMed ID: 30536925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo differences in the virulence, pathogenicity, and induced protective immunity of wboA mutants from genetically different parent Brucella spp.
    Wang Z; Niu J; Wang S; Lv Y; Wu Q
    Clin Vaccine Immunol; 2013 Feb; 20(2):174-80. PubMed ID: 23239800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brucella abortus mutants lacking ATP-binding cassette transporter proteins are highly attenuated in virulence and confer protective immunity against virulent B. abortus challenge in BALB/c mice.
    Truong QL; Cho Y; Park S; Park BK; Hahn TW
    Microb Pathog; 2016 Jun; 95():175-185. PubMed ID: 27057678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunochemical identification of Brucella abortus lipopolysaccharide epitopes.
    Rojas N; Freer E; Weintraub A; Ramirez M; Lind S; Moreno E
    Clin Diagn Lab Immunol; 1994 Mar; 1(2):206-13. PubMed ID: 7496947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and characterization of a Brucella abortus ATP-binding cassette transporter homolog to Rhizobium meliloti ExsA and its role in virulence and protection in mice.
    Rosinha GM; Freitas DA; Miyoshi A; Azevedo V; Campos E; Cravero SL; Rossetti O; Splitter G; Oliveira SC
    Infect Immun; 2002 Sep; 70(9):5036-44. PubMed ID: 12183550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.